Skip to main content

B 793 Pill - yellow capsule/oblong, 18mm

Pill with imprint B 793 is Yellow, Capsule/Oblong and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Rivastigmine is used in the treatment of Alzheimer's Disease; Parkinson's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 793

Rivastigmine tartrate 1.5 mg B 793

Rivastigmine Tartrate

B 793
1.5 mg
18.00 mm
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
Inactive Ingredients
hypromelloses, magnesium stearate, microcrystalline cellulose, silicon dioxide, gelatin, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "B 793"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.